Ethically Approved Phase I Clinical Trials
Written by Author on July 31st, 2009Clinical Trials by Europe’s leading Clinical Research Organisation
On the 12th February 2009 Richmond Pharmacology became the first CRO in Europe to gain ethics approval to conduct a Phase I healthy volunteer trial in healthy young females aged 14-17.
Richmond Pharmacology also provides Specialist TQT studies
Great Ormond Street Ethics Committee made the decision to permit this clinical trial and since then has allowed further studies of this nature to take place
A great achievement for Richmond Pharmacology was the recruitment of the first healthy young volunteers just sixteen days after gaining ethics approval on 28 Feb 2009.
A comparison (of the effect that an oral contraceptive pill has on the body) between females aged 14 – 17 and females aged 18 – 50 was the purpose of the study.
The study itself is typical of many Phase one medical trials of these compounds, however it is the population being included that makes this a pivotal study.
For many years the United Kingdom has been known for the conduct of good quality clinical studies across all phases. In recent years some trials that would typically be conducted in the UK have moved offshore to Eastern Europe and the Sub Continent. However the approval of this study marks a substantial shift in thinking and attitude towards clinical trial conduct in the UK and Richmond Pharmacology are proud to be at the centre of this pioneering move to once again make the UK THE place to conduct more specialised clinical research
In addition to providing high quality full service clinical studies, Richmond Pharmacology now has the proven ability to conduct a wide variety of studies complicated in their design and population required.
Richmond Pharmacology’s founding Directors are still at the heart of the company. Their hands on approach coupled with a dedicated and highly skilled staff ensure we are able to meet the challenges set by sponsors.